Page last updated: 2024-08-23

razoxane and Thyroid Neoplasms

razoxane has been researched along with Thyroid Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boehler, F; Breitfellner, G; Eiter, H; Fritzsche, H; Rhomberg, W	1
Chauvenet, A; Constine, LS; De Alarcon, PA; Friedman, D; London, WB; Mendenhall, NP; Schwartz, CL; Sposto, R; Tebbi, CK; Villaluna, D	1
Breitfellner, G; Eiter, H; Fritzsche, H; Gruber-Mösenbacher, U; Rhomberg, W	1

Trials

1 trial(s) available for razoxane and Thyroid Neoplasms

Article	Year
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chelating Agents; Cohort Studies; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid; Lung Diseases; Male; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Osteosarcoma; Razoxane; Risk Assessment; Risk Factors; Thyroid Neoplasms; Time Factors; Topoisomerase II Inhibitors	2007

Article

Year

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5

Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chelating Agents; Cohort Studies; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid; Lung Diseases; Male; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Osteosarcoma; Razoxane; Risk Assessment; Risk Factors; Thyroid Neoplasms; Time Factors; Topoisomerase II Inhibitors

2007

Other Studies

2 other study(ies) available for razoxane and Thyroid Neoplasms

Article	Year
Treatment options for malignant hemangioendotheliomas of the thyroid. International journal of radiation oncology, biology, physics, 2004, Oct-01, Volume: 60, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Hemangioendothelioma; Humans; Male; Middle Aged; Radiation-Sensitizing Agents; Razoxane; Survival Analysis; Thyroid Neoplasms	2004
[Prognosis and epidemiology of malignant hemangioendotheliomas of the thyroid gland]. Schweizerische medizinische Wochenschrift, 1993, Sep-04, Volume: 123, Issue:35 Topics: Aged; Austria; Combined Modality Therapy; Female; Hemangiosarcoma; Humans; Incidence; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Razoxane; Thyroid Neoplasms	1993